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O R I G I N A L  R E S E A R C H
Abstract: Sunscreen products are widely used to protect the skin from sun-related damage.
Previous studies have shown that some sunscreen chemicals are absorbed across the skin to
the systemic circulation. The current study shows that absorption into the skin of sunscreen
chemicals applied to the face is up to four times greater than that of the same product applied
to the back. This has implications for the way sunscreen products are formulated and may
allow the use of less potent products on the face compared with the rest of the body. The effect
of formulation vehicles on the release and skin penetration of the common sunscreen agent
benzophenone-3 (common name oxybenzone) was also assessed. Penetration of benzophenone-3
across excised human epidermis and high-density polyethylene (HDPE) membrane was
measured using in vitro Franz-type diffusion cells. Penetration and epidermal retention was
measured following application of infinite and finite (epidermis only) doses of benzophenone-3
in five vehicles: liquid paraffin, coconut oil, 50:50 ethanol:coconut oil, aqueous cream BP,
and oily cream BP. Highest benzophenone-3 skin retention was observed for the ethanol:coconut
oil combination. Maximal and minimal benzophenone-3 fluxes were observed from liquid
paraffin and coconut oil, respectively. The alcohol-based vehicle exhibited low benzophenone-3
release from the vehicle but high skin penetration and retention.
Keywords: sunscreen, skin penetration, vehicle effect, formulation, skin stripping
Introduction
Sunscreen products are widely used by adults and children to prevent sunburn, photo-
aging, and skin cancer. They are routinely applied to the arms and face for everyday
protection or to larger body surface areas during swimming and beach-related
activities. In addition, many cosmetics and hair products contain sunscreens, which
often results in the daily application of sunscreens without the user making a conscious
decision to use a sunscreen.
Sunscreens are applied topically to reduce the harmful effects of solar radiation
by the ability of their chemical structure to absorb, scatter, or reflect ultraviolet
radiation (UVR), thereby reducing the amount of UVR penetrating the skin. Topical
sunscreen agents can be classified into one of two groups: physical blockers, such as
titanium dioxide and zinc oxide, or chemical UV absorbers. Chemical sunscreens
are further classified into UVA and UVB absorbers according to their spectrum of
activity; for example, benzophenone-3 absorbs mainly in the UVB region, although
its activity does extend into the UVA range (Patel et al 1992). Consequently, sunscreen
products generally contain at least two chemical sunscreens to achieve a high sun
protection factor (SPF) and broad spectrum of UVR absorption. Physical sunscreens
are used in a limited number of sunscreen products as their inclusion creates a more
opaque product, which is not acceptable to all users. A recent investigation
demonstrated that the physical sunscreen titanium dioxide does not penetrate the
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skin (Schulz et al 2002). Development of micro- or
nanoparticulate titanium dioxide and zinc oxide (such as
Z-Cote,1 BASF Corporation,2 and ZinClear, Advanced
Nanotechnology Ltd3), which are transparent, may provide
more elegant sunscreen formulations. There has also been
the recent suggestion that titanium dioxide contributes to
significant photodegradation of the chemical sunscreen
benzophenone-3 (Serpone et al 2002). This interaction
creates free radicals that cause product destabilization and
low SPF values and could damage tissues.
Systemic absorption of some chemical sunscreens
following topical application to the skin has been reported
(Benson 2000; Fernandez et al 2000; Potard et al 2000;
Fernandez et al 2002; Chatelain et al 2003). Benzophenone-
3 has also been detected in the plasma, tissues, and urine of
animals (Okereke et al 1994). Hayden et al (1997) reported
that following topical application of a commercial sunscreen
product, 1%–2% of the applied dose of benzophenone-3
and its metabolites was excreted in the urine of human
volunteers. This was confirmed by Sarveiya et al (2004),
who also reported excretion of up to 1% benzophenone-3
and its metabolites following application of a sunscreen
product to human volunteers. In both studies, benzo-
phenone-3 was the only sunscreen detected in the urine,
despite the presence of a number of other sunscreen
chemicals in the applied product. Of the physicochemical
characteristics of benzophenone-3, in particular its partition
coefficient (calculated values for octanol:water partition
coefficient have been reported as log P = 2.63 and 3.58
[Agrapidis et al 1987; Treffel and Gabard 1996]) is
consistent with the optimal log P for maximum flux of
solutes through the skin reported by Roberts and Walters
(1998), and benzophenone-3 is thus more favorable for skin
penetration than the other more lipophilic sunscreen
chemicals. The more lipophilic sunscreens would be
expected to diffuse into the lipid-rich stratum corneum, but
only slowly partition into the more aqueous viable epidermis
and deeper tissues.
A number of properties may influence skin penetration
of sunscreen chemicals. These include the anatomical site
of application, age, skin condition, seasonal variations, and
the physicochemical properties of the sunscreen chemical
and the vehicle in which it is formulated. The anatomical
site to which a topical formulation is administered has been
shown to influence skin penetration of a number of drugs
(Roberts et al 1982; Wester and Maibach 1999). Sunscreen
products are most frequently applied to the face, yet testing
of products for SPF and other properties is normally
undertaken on the back. It is possible that these testing
procedures underestimate facial skin absorption.
Several studies have shown that the vehicle in which the
sunscreen is applied to the skin may influence dermal
absorption. For example, in a study of five different emulsion
types, the presence of lamellar liquid crystals and silicone
in emulsions with aqueous and oily external phases,
respectively, reduced the penetration rate of the sunscreen
octyl methoxycinnamate (ethylhexyl methoxycinnamate),
whereas the emulsifier-free oil-in-water emulsion showed
increased epidermal penetration (Lazar et al 1996). This
increase may be explained by the presence of propylene
glycol, which can act as an absorption enhancer. The water-
in-oil emulsion provided greatest retention of octyl
methoxycinnamate in the stratum corneum, suggesting that
preparations with oily external phases may provide
advantages with respect to low penetration rates and high
substantivity to the stratum corneum. In addition, regardless
of what vehicle was used, percutaneous absorption was
related to the concentration of filter in the emulsions.
Other studies have shown that the permeation of
benzophenone-3 through the horny layer was increased by
incorporation into white petrolatum and isopropyl lanolate
(Nannipieri et al 1990), and that the in vitro skin penetration
of octyldimethyl-PABA (para-aminobenzoic acid) was
greater from an alcoholic formulation than from a lotion
(Kenney et al 1995). In addition, in a comparison of an oil-
in-water emulsion-gel and petroleum jelly, the emulsion-
gel provided greater penetration into, and retention of three
UV filters (benzophenone-3, ethylhexyl methoxycinnamate
[common name octyl methoxycinnamate], and ethylhexyl
salicylate [common name octyl salicylate]) in the epidermis,
whereas the latter favored diffusion through the skin rather
than retention (Treffel and Gabard 1996). In comparing in
vitro human epidermal and polyethylene membrane
penetration and retention of benzophenone-3 from a range
of single phase solvents, it was reported that benzophenone-
3 penetration is minimized by topical application in vehicles
with a vehicle solubility parameter (δv) substantially
different from the solubility parameter of the membrane
(Jiang et al 1998). However, it is also noted that finite vehicle
conditions give a more realistic assessment of sunscreen
retention and penetration through skin than do infinite
vehicle dosing conditions (Cross et al 2001).
The influence of anatomical site (face versus back) on
the skin penetration of sunscreen chemicals from a
commercial product applied to human volunteers is
investigated. In addition, the skin penetration of
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benzophenone-3 following application as an infinite and
finite dose is investigated using an in vitro human skin
model. The influence of vehicle formulation on skin
retention and penetration is demonstrated for a number of
commonly used vehicles and formulations. Comparison of
the penetration across epidermal and HDPE membranes is
used to permit assessment of possible vehicle–skin
interactions.
Methods
Materials
Benzophenone-3 and bovine serum albumin (BSA,
fraction V) were supplied by Sigma-Aldrich Chemical Co
(Sydney, NSW, Australia), emulsifying ointment BP,
glycerol BP, and wool alcohol ointment BP were purchased
from David Craig & Co (Brisbane, QLD, Australia), light
liquid paraffin was the gift of Aloe Vera Industries Pty Ltd
(Loganholme, QLD, Australia), coconut oil was purchased
from The Oil Garden (Brisbane, QLD, Australia),
2-phenoxyethanol and magnesium sulfate were purchased
from Ajax Chemicals (Sydney, NSW, Australia), analytical
grade absolute ethanol was supplied by Merck Pty Ltd
(Kilsyth, VIC, Australia), and HDPE 20 µm membrane was
donated by Beaver Plastics (QLD) Pty Ltd (Coopers Plains,
QLD, Australia). High performance liquid chromatography
(HPLC) grade methanol was used for HPLC analysis, and
all other chemicals used in the study were of analytical grade.
In vivo study protocol
The study was approved by the University of Manitoba and
St Boniface Hospital Ethics Committees, and written
informed consent was obtained from all volunteers (5 male,
7 female, age range 22–61 years in the main study). The
study was a crossover design with sunscreen application to
the face or back on day 1, followed by application to the
other site on day 8 of the study. A commercially available
sunscreen lotion (SPF 30) containing 8% (w/v) homosalate,
7.5% (w/v) octyl methoxycinnamate, 6% (w/v) benzo-
phenone-3, and 5% (w/v) octyl salicylate was applied at a
rate of 2 mg/cm2 to an equal-sized area (112 cm2) on the
face or back of the volunteers. This application rate is greater
than OECD and COLIPA (the European Cosmetic Toiletry
and Perfumery Association) recommendation of an applied
dose between 0 and 10 mg/cm2 for skin penetration in vitro
assessment and application rate used in assessment of SPF
of 2 mg/cm2 (DHHS and FDA 1993; Stokes and Diffey
1999). However, in a preliminary study, when instructed to
“apply the sunscreen liberally as if they were on the beach”,
this was the application rate used by the volunteers. The
sunscreen lotion remained unoccluded for 8 hours before
being removed by washing the site. An area of the skin was
immediately tape stripped by application and removal of
Scotch crystal clear tape (3 cm × 1.9 cm). The tapes were
applied to the treated areas by application of a consistent
pressure along the tape. The stratum corneum was
sequentially stripped 16 times on the back and 6 times on
the face, and the strips were grouped for analysis by HPLC
with UV absorption detection (Sarveiya et al 2004) (group
1, strip 1; group 2, strips 2–6; group 3, strips 7–11; group 4,
strips 12–16). Tape stripping is a relatively noninvasive
technique which permits layers of the stratum corneum to
be collected from the treated area. It has been previously
reported that complete removal of the stratum corneum was
not possible even after 30–40 strippings (Hojyo-Tomoka
and Kligman 1972), and a certain barrier function in the
tissue so treated remains (Malkinson 1958; Feldmann and
Maibach 1965). The stripping procedure was not
normalized, since the inconsistent cohesion of the
corneocyte layers means that reproducible amounts of
stratum corneum (within and between subjects) cannot be
removed (Rougier et al 1987). Blood samples were taken
from all volunteers at pre-application baseline and at a
suitable steady-state time after application (7.5 hours), and
the urine output over 48 hours after application was
collected. The 7.5-hour time-point was determined on the
basis of a preliminary study in three volunteers with multiple
blood samples over a 48-hour period after application of
sunscreen (Sarveiya et al 2004). Sunscreen content in all
samples was analyzed by HPLC.
In vitro study protocol
Sunscreen formulation preparation
Five formulation vehicles were prepared with 2%
benzophenone-3, which was incorporated into the oil phase
in each case. The formulation vehicles investigated were
light liquid paraffin (LP), coconut oil (CO), 50:50
ethanol:coconut oil (EC), aqueous cream BP (AC), and oily
cream BP (OC). Creams were prepared from first principles
as described in the British Pharmacopoeia with benzo-
phenone-3 incorporated in the oil phase during preparation.
Membrane diffusion studies
Approval was obtained from the University of Queensland
and Wesley Hospital Medical Ethics Committees for
collection and use of human skin. Human epidermal tissue
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(abdominal region of a single female) was obtained by blunt
dissection of full-thickness skin and heat separation
(Kligman and Christophers 1963). Epidermis was air-dried
and stored at –20 °C.
Prior to use, human epidermis was thawed at room
temperature and HDPE membranes were rinsed with
distilled water before mounting between donor and receptor
chambers of horizontal Franz-type diffusion cells. The
surface area available for diffusion was 1.18 cm2 and the
receptor chamber volume approximately 3.4 mL. BSA (4%)
in phosphate-buffered saline (pH 7.4) was placed in the
receptor chambers (Dal Pozzo et al 1991) and stirred
throughout the experimental period with magnetic stirring
bars. Diffusion cells were equilibrated at 37 ± 0.1 C in a
blacked-out water bath (to protect sunscreen from potential
photo-degradation) for at least 1 hour prior to application
of the benzophenone-3 formulations. An aliquot of each
formulation (200 mg/cm2) was applied to the epidermal
surface under occlusion (by placing a cover-slip on the donor
compartment) for the infinite dose studies and 20 mg/cm2
of each formulation applied without occlusion for the finite
dose studies. For HDPE membrane, 1 g of each formulation
was applied under occlusion. The contents of the receptor
chamber were removed and replaced periodically for 8 or
24 hours following application to HDPE or epidermal
membranes, respectively. A 100-µL sample from each
receptor phase volume was mixed with 200 µL
acetonitrile:methanol (95:5), refrigerated for 15 minutes then
centrifuged at 10 000 g for 10 minutes to precipitate the
protein prior to HPLC assay. At the end of each study the
membrane was wiped with soft tissue and distilled water.
Benzophenone-3 remaining in the epidermis (Rs, µg) was
extracted twice with methanol and quantified by HPLC. This
procedure had been previously validated as providing a
recovery of 96.7%. Five or six replicates were conducted
for the epidermis (infinite or finite dose, respectively) and
four for the HDPE membrane.
HPLC analysis
Sunscreen content in all in vitro and in vivo samples was
quantified by HPLC assay with UV detection (Sarveiya et
al 2004). Samples were prepared for analysis as described.
Excellent linearity was obtained over the range 0.1–5.0 µg/mL
for all sunscreens. Lower limits of detection and quantitation,
calculated as greater than 3 or 10 times the baseline noise
in the assay, respectively, were 0.8 and 2 ng for benzo-
phenone-3, 0.3, and 1 ng for octyl methoxycinnamate, and
2 and 4 ng for octyl salicylate and homosalate. Extraction
procedures from BSA receptor fluids (0.5 mg/mL), plasma
(0.5 mg/mL), urine (5 mg/mL), and skin were validated at
> 98%, 97%, 86%, and 98% recovery, respectively.
Data analysis
A plot of the total amount penetrated (µg/cm2) versus time
was prepared for infinite dose applications on epidermis
and HDPE and for the finite dose application to epidermis.
The slope of the linear portion gave the flux Js or Jm
(µg/cm2•h) for epidermis and HDPE, respectively.
Membrane flux was assumed to be related to the
permeability coefficient (Kp, cm/h) and the concentration
gradient of the solute across the membrane (ΔC, µg/cm3):
J = Kp ΔC (1)
Kp values are useful for comparing penetration profiles for
solutes from a range of formulation vehicles as they relate
to the rate of diffusion of the solute within the membrane
adjusted for concentration differences. In the infinite dose
study, negligible donor depletion occurred and receptor sink
conditions were maintained; therefore, ΔC is defined by the
initial benzophenone-3 vehicle concentration (Cv).
The ratio of Kps obtained from epidermis and Kpm from
HDPE was used to evaluate the effect of benzophenone-3
or vehicle on skin permeability, as described previously
(Jiang et al 1997), and noted briefly:
(Js/ΔCs) / (Jm /ΔCm) = Kps /Kpm (2)
since ΔCs = ΔCm,
Js /Jm = Kps/Kpm
An apparent diffusion parameter ds of solute in the epidermis
is defined as the ratio of solute flux to that retained in the
epidermis (Rs) at steady state, while an apparent partition
parameter κs may be defined from Rs and Cv as (Jiang et al
1998):
ds = Js /Rs κs = Rs /Cv (3)
Statistical methods
Differences between the flux and the intercept of the amount
versus time plots, for infinite dose application in each of
the vehicles, were assessed using multiple regression with
pairwise comparisons. For the finite dosing study,
differences between the maximum amount of benzo-
phenone-3 penetrated to the receptor were assessed by
comparing the means of each formulation. This utilized one-
way ANOVA (analysis of variance) followed by Tukey’s
HSD post-hoc test.
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Results and discussion
In vivo study
Figure 1 shows a substantial amount of all sunscreen
chemicals in the stratum corneum of the back after 8 hours,
a finding which is consistent with previously published in
vitro research (Treffel and Gabard 1996; Jiang et al 1999).
Greater amounts of sunscreen were present in the superficial
layers (ranging from approximately 4% to 10% of the
applied dose in groups 1 and 2 combined) than in deeper
layers. This is a desirable outcome, as the target activity of
sunscreens is in the superficial layers of the skin where they
will absorb potentially damaging UVR to minimize
penetration to deeper viable tissues where damage may
occur.
Figure 2 shows a comparison of the distribution of
sunscreens in the stratum corneum of the face and back of
the volunteers. Approximately two to four times the amount
of sunscreen was present in the superficial stratum corneum
layers of the face compared with the back. The difference
in absorption between the anatomical sites was statistically
significant for benzophenone-3, octyl salicylate, and
homosalate, but not for octyl methoxcinnamate. The
percentage of applied dose of sunscreen in the six superficial
layers of the stratum corneum was approximately 10%, 18%,
18%, and 25% for homosalate, octyl methoxycinnamate,
benzophenone-3, and octyl salicylate, respectively. This
finding is consistent with previous studies that have
demonstrated anatomical differences in the skin penetration
of other chemicals (Rougier et al 1986). Experimental
protocols for skin stripping vary, with some scientists
discarding strip 1 data as non-penetrated material. In the
current study the skin surface was washed prior to skin
stripping to remove non-penetrated sunscreen. Nevertheless,
the first strips were analyzed and plotted separately to allow
interpretation including and excluding the first strip (Figures
1 and 2).
Further, sunscreens were not detected in the plasma or
urine samples of the volunteers in the present study. Such
an outcome is desirable, as it is undesirable that sunscreen
chemicals be absorbed either into viable tissues within the
skin or into the systemic circulation. These findings appear
to be at variance with our previous work in which
benzophenone-3 and/or metabolites were detected in the
plasma and urine (Hayden et al 1997; Sarveiya et al 2004).
However, only a small surface area of skin was used for
application in this study, whereas in previous studies,
application occurred to extensive areas of the body.
Consequently, in this study the sunscreen chemicals or
metabolite levels were below the detectable limits of the
HPLC assay.
Infinite dose in vitro study
Membrane and epidermal penetration and retention data for
application of an infinite dose of benzophenone-3 in a range
of formulation vehicles are shown in Table 1, with the
penetration versus time profiles shown in Figure 3.
Comparison of the five formulation vehicles showed that
significant differences existed between all five formulations
with respect to penetration of benzophenone-3 across HDPE
membrane following application of an infinite dose in a
range of formulation vehicles. LP showed the highest flux,
followed by OC > AC > 50:50 EC > CO. In the case of
benzophenone-3 penetration across epidermal membrane,
LP again had greatest flux, followed by 50:50 EC, though
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the difference between these two vehicles was not significant
(p = 0.087). The order of benzophenone-3 flux for the
remaining vehicles was OC > AC > CO. Significant
differences (p < 0.05) existed between the benzophenone-3
fluxes across epidermis for all formulation vehicles except
LP and EC. The ratio of apparent permeability coefficient
of benzophenone-3 through epidermis (Kps), to apparent
permeability coefficient of benzophenone-3 through
polyethylene (Kpm) for each formulation, is noted in Table 1.
This shows that Kps/Kpm was greatest for 50:50 EC (3.17),
followed by AC (1.73), with the other vehicles having similar
data (≅ 0.8).
Measurement of benzophenone-3 penetration following
application of an infinite dose of solute to a membrane
permits assessment of steady-state flux and apparent
permeability coefficient (as noted in Table 1) and thereby
allows evaluation of vehicle effects on membrane
penetration. Formulation vehicle significantly influences the
penetration of benzophenone-3 across HDPE membrane,
with flux greatest from LP > OC > AC > EC > CO. Flux
across HDPE represents the partitioning of benzophenone-
3 from the vehicle to the receptor and thereby provides a
means of comparing release of benzophenone-3 from each
of the vehicles. The difference in benzophenone-3 release
from the two oils reflects their solubility of 29 mg/mL in
LP and 133 mg/mL in CO (Jiang et al 1998), showing that
the slow release rate of benzophenone-3 from CO is due to
its higher affinity to this solvent. Benzophenone-3 has low
solubility in ethanol (≈2%); therefore, the slow release of
benzophenone-3 from EC is most probably due to its affinity
to the CO. In the case of the cream/emulsion formulations,
benzophenone-3 is likely to exist predominantly in the oil
phase, reflecting its octanol/water partition coefficient (log
P = 2.63–3.58: Agrapidis et al 1987; Treffel and Gabard
1996). As OC is a water-in-oil emulsion, benzophenone-3
will be predominantly in the external phase, whereas it will
be in the internal phase of the oil-in-water emulsion AC.
Thus benzophenone-3 release from AC requires a
partitioning step from oil to water phase prior to release,
which is likely to contribute to the slower release rate
compared with OC. This may be less relevant in the clinical
situation where the sunscreen formulation is rubbed into
the skin. Comparing flux across HDPE and epidermis, as
expected, flux across epidermis was less than HDPE because
of the barrier to penetration presented by the epidermal
membrane. The pattern of benzophenone-3 flux from each
of the vehicles was similar for both membranes with the
Table 1 Penetration of benzophenone-3 from each of the
vehicles studied following application of an infinite dose to
human epidermis or high-density polyethylene (HDPE)
membrane
Vehicle
Parametera LP CO EC AC OC
Js 9.25 1.64 7.95 5.26 6.16
Jm 54.22 9.15 12.56 14.26 42.53
Rs
b 30.2 ± 6.1 14.8 ± 10.6 60.0 ± 8.4 24.0 ± 1.6 23.5 ± 2.3
Kps 2.3 × 10
–3 4.1 × 10–4 2.0 × 10–3 1.2 × 10–3 1.65 × 10–3
Kpm 2.7 × 10
–3 4.73 × 10–4 6.3 × 10–4 7.1 × 10–4 2.1 × 10–3
Kps/Kpm 0.84 0.86 3.17 1.73 0.77
ds 0.61 0.09 0.27 0.44 0.53
κs 7.5 × 10
–4 9.4 × 10–4 1.5 × 10–3 6.0 × 10–4 5.87 × 10–4
a Units: J = µg/cm2 • h; R = µg; d = cm–2 • h–1; κ = cm–3.
b Mean ± SEM of 5 replicates.
Abbreviations: AC, aqueous cream; CO, coconut oil; EC, ethanol:coconut oil;
LP, liquid paraffin; OC, oily cream; m, HDPE membrane values; s, epidermis values;
J, flux; Rs, amount remaining in epidermis; Kp, permeability coefficient;
d, diffusion; κ, apparent partition.
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exception of the EC vehicle, which showed a relatively
higher penetration across epidermis compared with the other
vehicles. This difference is attributed to vehicle–skin
interactions as described below.
Percutaneous absorption involves two processes, namely
partitioning of the solute from its vehicle to the skin,
followed by permeation of the solute through the skin. The
vehicle can potentially influence both processes via vehicle–
solute interactions and vehicle–skin interactions. Vehicle–
solute interactions will influence the rate and extent to which
the solute is released from the vehicle, while vehicle–skin
interactions result in penetration enhancement or retardation
(Roberts 1991). In this study, penetration of benzophenone-
3 across HDPE membrane provides a measure of vehicle–
solute interaction (ie, benzophenone-3 release from the
vehicle), as the vehicles do not interact with the synthetic
membrane to influence penetration (Jiang et al 1997, 1998).
In contrast, flux of benzophenone-3 across skin can be
influenced by both vehicle–solute interactions, which affect
benzophenone-3 release from the vehicle, and vehicle–skin
interactions. In order to elucidate which interactions are
occurring for each of the vehicles, a ratio of apparent
permeability coefficient for benzophenone-3 across skin and
HDPE membrane was calculated (Kps/Kpm; Table 1).
Kps/Kpm for LP, CO, and OC are similar and close to 1,
which suggests that these vehicles do not interact with the
skin to influence penetration. Comparison of penetration
across skin and HDPE following application of benzo-
phenone-3 in the mixed EC vehicle shows a marked increase
in Kps /Kpm (3.2 compared with 0.86 for CO alone),
suggesting that this vehicle is enhancing penetration of
benzophenone-3 across the epidermis. This was not
unexpected, as the penetration-enhancing effect of ethanol
has been demonstrated previously for other compounds and
is thought to be due to extraction of stratum corneum lipids
(Scheuplein and Blank 1973; Barry 1987). Mixed ethanol
and oil vehicles are used for some commercial sunscreen
spray formulations.
The Kps/Kpm for AC (1.73) also suggests that this vehicle
enhances skin penetration of benzophenone-3. The cause
of this penetration enhancement is unclear, but it may be
suggested that AC increases hydration of the skin. Evidence
for increased skin penetration by hydration has been well
reported in the scientific literature (McKenzie and Stoughton
1962), and it has been suggested that oil-in-water emulsions,
such as AC, may donate water to the stratum corneum to
increase hydration (Barry 1983). In addition, AC contains
surfactants (sodium lauryl sulfate and cetostearyl alcohol),
which may enhance skin penetration (Tupker et al 1990).
In contrast, OC which is a water-in-oil emulsion, did not
appear to influence skin penetration, although it has been
suggested that this vehicle may increase stratum corneum
hydration by retarding water loss because of its occlusive
nature (Barry 1983). However, in the infinite dose study an
occluded diffusion cell system was used, so any occlusive
influence of the vehicle would not be seen.
Finite dose in vitro study
Penetration data obtained following application of a finite
dose of benzophenone-3 in each of the formulation vehicles
to epidermal membrane are summarized in Table 2, with
the penetration versus time profiles shown in Figure 4. The
percentage of applied dose absorbed ranged between 1.97%
from CO and 9.97% from LP. Comparison of the maximum
amount of benzophenone-3 penetrated showed that LP and
CO significantly differed from each other and the remaining
formulations, but no other comparisons were significantly
different.
Application of a finite dose of formulation to skin permits
a closer approximation of “in-use” conditions. Defining an
appropriate finite dose can be problematic. A dose of
2 mg/cm2 has been recommended for assessment of the SPF
of sunscreen formulations (Lowe et al 1997). However, for
adequate sun protection, sunscreen manufacturers and health
promotion organizations recommend that sunscreens should
be applied liberally with frequent reapplication throughout
Table 2 Penetration of benzophenone-3 from each of the vehicles studied following application of a finite dose to human epidermis
Vehicle
LP CO EC AC OC
Maximum amount penetrated at 8 h 46.6 ± 3.9 9.3 ± 0.6 22.9 ± 0.9 20.9 ± 0.8 30.3 ± 2.4
(µg/cm2 ± SEM; n = 6)
% absorbeda 9.97 1.97 4.86 4.43 6.41
Rs (µg ± SEM) 9.2 ± 1.9 9.5 ± 1.9 133.2 ± 19.3 9.7 ± 0.8 16.1 ± 4.8
% retainedb 1.94 2.00 28.22 2.04 3.42
a Percentage of dose applied penetrating across epidermis to receptor over 8-hour application period.
b Percentage of dose applied retained in epidermis at 8 hours after application.
Abbreviations: AC, aqueous cream; CO, coconut oil; EC, ethanol:coconut oil; LP, liquid paraffin; OC, oily cream; Rs, amount remaining in epidermis.
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a period of sun exposure and swimming. A pilot study was
conducted in which five adult volunteers were asked to apply
sunscreen as they would normally do on the beach. A mean
application rate of 20 mg/cm2 was determined. As a result,
this was used as the rate of application in the finite dose
study. When each of the formulations was applied at this
rate, the percentage of applied dose absorbed ranged from
1.9% for CO to 9.3% for LP, the difference being significant
for these two formulations only. This is a substantial level
of absorption given that a sunscreen generates its therapeutic
effect on the skin surface and superficial layers and ideally
should not penetrate to deeper tissues or the blood
circulation. Previous studies have reported up to 10% of an
applied finite dose absorbed from commercial sunscreen
formulations (Jiang et al 1999) and 5% from petroleum jelly
(Treffel and Gabard 1996). The order of percentage absorbed
for the formulations was: LP > OC > EC > AC > CO. When
comparing penetration following infinite and finite dose
application to epidermis, there is a reversal in the 50:50 EC
and OC formulations. From Figure 4 it appears that initially
the flux of benzophenone-3 from EC is higher than from
OC, but from approximately 2 hours the flux decreases. This
most likely occurs because initially the ethanol present has
an enhancement effect on benzophenone-3 penetration but
as the ethanol evaporates from the donor formulation this
effect is lost and benzophenone-3 flux reduces to that seen
for CO alone. This may also contribute to the much higher
skin retention of benzophenone-3 following application of
the EC formulation, which is of the order of 10 times that
obtained from the other formulations (67 µg for EC
compared with 5–8 µg for the other formulations), as
discussed below. We have previously reported that different
profiles between finite dose and infinite doses can occur
when formulations with different viscosities are used (Cross
et al 2001). Greater penetration is evident with finite doses
of high viscosity formulations than with lower viscosity
products. The reverse occurs with infinite dose formulations.
Epidermal retention
With the application of an infinite dose the amount of
benzophenone-3 remaining in the epidermis (Rs) at the
completion of the experiment was shown not to be
significantly different between the five formulations
(Table 1). However, following application of a finite dose
of benzophenone-3, all formulations showed similar
retention with the exception of 50:50 EC, which showed
significantly higher retention within the epidermis (Table 2;
p < 0.05). It is interesting to note that despite the application
of a smaller amount of benzophenone-3, the amount retained
in the epidermis is greater following application of the finite
dose than the infinite dose (66.6 ± 9.6 and 30.0 ± 2.4 µg,
respectively). It is postulated that ethanol is increasing
penetration of benzophenone-3 into the stratum corneum
but as it evaporates it leaves the benzophenone-3 in CO, a
vehicle for which it has high affinity. Thus, flux across the
epidermis decreases to that seen for the CO vehicle, leaving
a high loading of benzophenone-3 within the stratum
corneum. As the ethanol evaporates from the vehicle, this
will also concentrate the sunscreen in the remaining vehicle,
which would also increase benzophenone-3 skin retention.
In a clinical setting, this benzophenone-3 may then penetrate
into the viable epidermis and deeper tissues or blood supply
over time.
Conclusions
We conclude that sunscreen chemicals applied to the skin
are substantially retained in the superficial layers of the
stratum corneum, thereby optimizing sunscreen efficacy and
minimizing potential interaction between these chemicals
and viable tissues. Absorption and retention of sunscreens
in the stratum corneum of the face is higher than the back
and arms (Sarveiya et al 2004). This anatomical difference
in skin absorption is in accordance with literature on a range
of chemicals. We have also shown that release and skin
penetration of the sunscreen benzophenone-3 was
influenced by the formulation vehicle in which it was applied
to the membrane. With the exception of the alcohol-based
formulation, the penetration profile was the same for both
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infinite and finite dosing. The alcohol:coconut oil based
formulation provided low benzophenone-3 release from the
vehicle but high benzophenone-3 penetration across
epidermis, most probably due to the enhancer effects of
ethanol on the stratum corneum barrier. When applied as a
finite dose, mimicking the real-life situation, the effect of
the alcohol was less pronounced as it evaporated from the
formulation.
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Notes
1 Use of trade names is for product identification only and does not imply
endorsement.
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